Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells

被引:74
作者
Distler, JHW
Jüngel, A
Caretto, D
Schulze-Horsel, U
Kowal-Bielecka, O
Gay, RE
Michel, BA
Müller-Ladner, U
Kalden, JR
Gay, S
Distler, O [1 ]
机构
[1] Univ Zurich Hosp, Ctr Expt Rheumatol, Dept Rheumatol, CH-8091 Zurich, Switzerland
[2] Univ Erlangen Nurnberg, D-8520 Erlangen, Germany
[3] Med Univ Bialystok, Bialystok, Poland
[4] Univ Giessen, D-35390 Giessen, Germany
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 01期
关键词
D O I
10.1002/art.21497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Monocyte chemoattractant protein I (MCP-1; CCL2) has been implicated-in the pathogenesis of fibrotic diseases and is up-regulated in patients with systemic sclerosis (SSc). The aim of the present study was to examine the mechanisms by which MCP-1 mediates its profibrotic effects in the setting of SSc. Methods. The expression of receptors for MCP-1 on dermal fibroblasts was analyzed by real-time polymerase chain reaction and fluorescence-activated cell sorting. The ability of extracellular matrix proteins to bind and release MCP-1 was quantified by enzyme-linked immunosorbent assay. Th0 cells were isolated using a magnetic-activated cell sorting system and were stimulated twice in the presence of MCP-1. The synthesis of collagen was measured using the Sircol collagen assay kit. Results. The glycosaminoglycan chondroitin sulfate, but not fibronectin or collagens, bound and released MCP-1 in a time-dependent manner. MCP-1 that was released from chondroitin sulfate induced the differentiation of interleukin-4 (IL-4)-producing T cells in a dose-dependent manner. In turn, dermal fibroblasts from patients with SSc expressed IL-4 receptor, and stimulation with IL-4 significantly increased the production of collagen in dermal fibroblasts. In contrast, CCR2a and CCR2b, as well as D6 and US28 (other potential receptors of MCP-1), were not detectable in SSc and normal fibroblasts, and their expression was not induced by platelet-derived growth factor, IL-1 beta, or IL-4. In addition, MCP-1 had no direct effects on collagen production by fibroblasts. Conclusion. MCP-1 has no direct effects on dermal fibroblasts but contributes to fibrosis in patients with SSc by inducing the differentiation of IL-4-producing T cells. Because MCP-1 has both proinflammatory and profibrotic effects, pharmacologic targeting of MCP-1 could be a promising therapeutic approach in SSc.
引用
收藏
页码:214 / 225
页数:12
相关论文
共 50 条
  • [1] PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
    不详
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (05): : 581 - 590
  • [2] BUCKINGHAM RB, 1983, J LAB CLIN MED, V101, P659
  • [3] Lysine 58 and histidine 66 at the C-terminal α-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding
    Chakravarty, L
    Rogers, L
    Quach, T
    Breckenridge, S
    Kolattukudy, PE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) : 29641 - 29647
  • [4] Chemokines in the pathogenesis of vascular disease
    Charo, IF
    Taubman, MB
    [J]. CIRCULATION RESEARCH, 2004, 95 (09) : 858 - 866
  • [5] Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor α
    Chizzolini, C
    Parel, Y
    De Luca, C
    Tyndall, A
    Åkesson, A
    Scheja, A
    Dayer, JM
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : 2593 - 2604
  • [6] Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC)
    Dawson, TC
    Lentsch, AB
    Wang, ZX
    Cowhig, JE
    Rot, A
    Maeda, N
    Peiper, SC
    [J]. BLOOD, 2000, 96 (05) : 1681 - 1684
  • [7] Denton CP, 1998, CLIN EXP IMMUNOL, V114, P293
  • [8] Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-κB and simian virus 40 promoter factor 1 pathways
    Distler, JHW
    Hagen, C
    Hirth, A
    Müller-Ladner, U
    Lorenz, HM
    del Rosso, A
    Michel, BA
    Gay, RE
    Nanagara, R
    Nishioka, K
    Matucci-Cerinic, M
    Kalden, JR
    Gay, S
    Distler, O
    [J]. MOLECULAR PHARMACOLOGY, 2004, 65 (02) : 389 - 399
  • [9] Distler O, 2001, ARTHRITIS RHEUM-US, V44, P2665, DOI 10.1002/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO
  • [10] 2-S